How many drug targets are there?
John P. Overington(Mundipharma (United Kingdom)), Bissan Al‐Lazikani(Mundipharma (United Kingdom)), Andrew L. Hopkins(Pfizer (United Kingdom))
Cited by 3,493
Abstract
Related Papers
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al.|Advanced Drug Delivery Reviews|2001|17.8k